SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-17-009106
Filing Date
2017-02-14
Accepted
2017-02-14 13:04:41
Documents
1
Group Members
BONG KOHNIMISH SHAHVENROCK HEALTHCARE CAPITAL PARTNERS II, L.P.VHCP CO-INVESTMENT HOLDINGS II, LLCVHCP CO-INVESTMENT HOLDINGS, LLCVHCP MANAGEMENT II, LLCVHCP MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a17-4306_1sc13ga.htm SC 13G/A 330833
  Complete submission text file 0001104659-17-009106.txt   332722
Mailing Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301
Business Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301 6504625800
Ocera Therapeutics, Inc. (Subject) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86177 | Film No.: 17606172
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 530 FIFTH AVENUE 22ND FLOOR NEW YORK NY 10036
Business Address 530 FIFTH AVENUE 22ND FLOOR NEW YORK NY 10036 650-475-3734
VENROCK HEALTHCARE CAPITAL PARTNERS LP (Filed by) CIK: 0001458177 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A